<DOC> 
<DOCNO>1031111_business_story_2558825.utf8</DOCNO> 
<TEXT> 

The Telegraph - Calcutta : Business
 Tuesday, November 11, 2003 				 Win Medicare charts growth strategy
 A STAFF REPORTER																								Calcutta, Nov. 10: Win Medicare has set a target to achieve a turnover of Rs 200 crore in the next couple of years. Its existing turnover is Rs 120 crore. The Modi group company, which has several leading over-the-counter range of products like Betadine and Hepamerz, is planning to expand its business through tie-ups with pharma multinationals to get licences for more products.																								Vice-president (sales and marketing) Surjit Aurora said the company is also keen to get into countrywide retailing business. The over-the-counter brands and retailing business should help us grow in the next few years, Aurora said.																								The company has licence tie-ups with Mundi Pharma, Tillotts Pharma and IBSA of Switzerland, Merz Pharma of Germany, HRA Pharma of France and Orion Pharma of Finland. 
</TEXT> 
</DOC>